The meeting focused on new developments further pushing the frontier of horizon scanning data made available for IHSI member states. The first in world definition and methodology for automated identification of drug class and the related new intelligence function of “emerging drug class” have seen its final steps and will be launched soon once rigorous […]
On 26 June 2025, the IHSI Executive Committee (EXCO) convened in Lisbon for its annual meeting. The Chair Diana Delnoij, welcomed all face-to-face and virtual participants by reaffirming the organisation’s commitment to advancing health systems intelligence across Europe. The Quality Management Committee (QMC) shared a concise update on the IHSI Database progress, ensuring alignment across […]
In April 2025, the International Horizon Scanning Initiative (IHSI) unveiled its newlyredesigned website, marking a significant step forward in its mission to support governmentswith horizon scanning data for informed healthcare decision-making. The updated platform,accessible at ihsi-health.org, offers a more intuitive user experience, streamlined navigation,and enriched content to better serve policymakers, researchers, and healthcare stakeholders. The revamped […]
The system is based on the joined best practices of all IHSI memberstates.
A comprehensive global database tracking pharmaceutical developments from clinical trial phase I to market access approval.
Our specialised AI model utilizes LLM, NLP and machine learning, for data harvesting and curation, ensuring best-in-class data.
It is record based. Each record represents one indication of an individual pharmaceutical product; Each record has 152 unique data fields. Updated every 28 days.
Contact us
If you want to reach out to us, please leave a message and we will get in touch with you as soon as possible.